Antero Midstream Posts Solid Q1; Execution on Track

What happened

Antero Midstream reported its first quarter 2026 results on April 29, reinforcing the steady fee-based cash flow profile outlined in our master report. The release, while light on numeric detail, comes amid a backdrop of eleven consecutive quarters of positive free cash flow after dividends and non-GAAP leverage at 2.7x as of Q3 2025. Management's guidance for 2025 Adjusted EBITDA of $1.08-1.12 billion and FCF after dividends of $250-300 million remains unchanged, reflecting stable volumes from Antero Resources' Marcellus drilling program. The pending HG Midstream acquisition and Utica divestiture, expected to close in Q2 2026, promise to add >$100 million in asset-level FCF while keeping leverage near 3x. The Q1 results therefore validate the existing thesis of a 5% yield with mid-single-digit growth, albeit with execution risk centered on the HG integration.

Implication

For existing holders, the Q1 release provides no reason to alter position sizing; the near-term catalyst is the HG-Utica transaction closing and initial 2026 guidance in coming months. For new investors, the stock at $17-18 offers a ~5% yield with modest upside if management delivers on its leveraged-neutral, FCF-accretive M&A plan. However, the single-customer dependency on Antero Resources and the risk of AR cutting drilling in a sub-$3 gas environment cap the upside and warrant a 'potential buy' with a $17 attractive entry and $21 trim level. The lack of detailed Q1 numbers in the release is a minor negative—investors should seek the 10-Q for full financials before concluding on trends.

Thesis delta

The Q1 announcement is a non-event that neither strengthens nor weakens the investment thesis materially. The core assumptions—steady AR-linked volumes, stable dividend, and HG accretion—remain intact, and no new data point challenges the base-case 10-15% annualized return. The thesis thus stands unchanged, with the next inflection point being the HG integration execution and 2027 guidance.